SynthesisThe Journal of international medical research2020

Is nab-paclitaxel better than conventional taxanes as neoadjuvant therapy for breast cancer? A meta-analysis.

Yong Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.